[Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004357:Drug Synergism; D005839:Gentamicins / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010118:Oxytetracycline / Q000494:pharmacology*; D010406:Penicillins / Q000627:therapeutic use*; D011549:Pseudomonas / Q000187:drug effects*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D012293:Rifampin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D012293:Rifampin; D010118:Oxytetracycline
Empleo de nuevos antibióticos en la terapia de infecciones por seudomonas. I. Pruebas "in vitro".